BioPartnering North America

BioPartnering North America

November 29, 2006 12:47 ET

BioPartnering North America 'BPN' Fosters Life Science Partnerships Offers Unparalleled Opportunities for Business Development

SANTA CRUZ, CALIFORNIA--(CCNMatthews - Nov. 29, 2006) - Technology Vision Group LLC (TVG) is pleased to announce that as BioPartnering North America (BPN: enters its fifth year, its popularity continues to grow as it attracts top international players from the biotechnology, pharmaceutical and financial industries. Following the same format as its successful sister conference BioPartnering Europe (BPE), which was held in London last month, BPN provides a host of business development opportunities for innovative biotech companies from across the world in one of the most dynamic partnering conferences in North America.

BPN will be held in Vancouver, B.C., Canada, on February 4-6, 2007 as a partnership between TVG, BC Biotech, BioAlberta and BIOTECanada. For full details of how to register for BPN, and take advantage of the Early Bird delegate rate (available until January 2nd 2007) please see Fosters B2B Opportunities

One of the reasons for the success of BPN is, a unique and powerful internet tool and business intelligence system developed by TVG to facilitate partnering meetings. Registered delegates have access to, allowing them to search for partnering opportunities through keyword searches of detailed company profiles and to contact other delegates. Starting December 1, 2006, delegates will also be able to arrange private meetings and reserve meeting space in advance of the conference.

" is the best pharmaceutical and biotechnology partnering online tool that I have used," states Bob Seeman, CEO of Clera, Inc. of Ontario. "It is powerful and flexible and provides the information that I need to efficiently target and contact prospects that are relevant to my partnering objectives."

"The quality and efficiency of the system allows you to save tens of thousands of air miles to conduct the same number of high quality meetings," commented M. Murray, SVP Business Development at Amura Ltd.

Video Presenting Company Profiles on

TVG is excited to offer video profiles to presenting companies at BPN 2007. This exciting feature gives Open House and Emerging Company presenters the ability to add a short video to their profile and thus promote their company in a dynamic and engaging manner. This additional video capability within demonstrates BPN's commitment to finding new ways to showcase companies, and reaffirms's position as the leading life science conference collaboration tool, enabling BPN presenters to achieve maximum effectiveness from their conference experience.

For a video profile demonstration please see:

Applications to Present are Still Being Accepted

As well as state-of-the-art partnering facilities, BPN provides biotech companies with plenty of showcase opportunities. This year there will be 22 Emerging Company presentations which feature companies that were founded in or later than 2002 in 14-minute podium presentations in the main plenary hall. Another trademark of BPN is the Open House presentations, which will feature 56 biopharmaceutical and diagnostics companies, each giving interactive presentations in specially constructed booths. TVG is still accepting applications to present, which can be submitted online at

Full details about BioPartnering North America online at:

Conference Sponsors

Angiotech Pharmaceuticals, Inc., AstraZeneca, PricewaterhouseCoopers, Cooley Godward Kronish LLP, Farris, Vaughan, Wills & Murphy LLP, Ferghana Partners Group, Morrison & Foerster, Pfizer, Bristol-Myers Squibb Company, Merck & Co., Inc., Ministry of Advanced Education, NovaQuest, Novartis, QLT Inc., Seed Intellectual Property Law Group PLLC, UK Trade & Investment, anapharm, Genome British Columbia, Life Science Analytics, Marsh Canada Limited, UBC University - Industry Liaison Office

Conference Supporters

Bio Business, BioExecutive International, Biotechnology Focus, BioWorld Today, CCNMatthews , Citigate Dewe Rogerson, Contact Canada®, European Biopharmaceutical Review, Nature Biotechnology, U.S. Commercial Service, Global Bioscience Partnership

2007 Emerging Company Presenters

Amkor Pharma, Inc., Aquinox Pharmaceuticals, Clone-E Therapeutics, Colby Pharmaceuticals, EUSA Pharma Inc, GammaCan Int. Inc., Jennerex Biotherapeutics Inc., Kinexis Inc., Merrion Pharmaceuticals Limited, Royalmount Pharma.

2007 Open House Presenters

Aegera Therapeutics Inc., Affibody, Alimentary Health Ltd, Alphora Research Inc., Aspreva Pharmaceuticals, Athenagen, Avid Bioservices, Axela Biosensors Inc., BioWa, Inc., Cell Genesys, Inc., Celldex Therapeutics, Centre for Translational and Applied Genomics, ChemokineTherapeutics, CombinatoRx, Cytokinetics, Inc., enGene, Epeius Biotechnologies Corporation, F2G Limited, Forbes Medi-Tech Inc., Hunter-Fleming Limited, Ichor Medical Systems, Inc., ICPbio Limited, Ingenium Pharmaceuticals AG, Inimex Pharmaceuticals, Inc., InNexus Biotechnology Inc., KAI Pharmaceuticals, MaxCyte, Inc., NAL Pharmaceuticals Ltd, NascaCell Technologies AG, NovaDel Pharma, Novation, NPIL Pharma Torcan, Orphan Australia Pty Ltd, Patheon Inc., PIERIS AG, Resverlogix Corp., SemBioSys, SR Pharma plc. / Atugen AG, Stem Cell Therapeutics, Syntaxin, Trigen Holdings AG, Tripos Discovery Research, Vertical i, Inc., Virxsys Corporation, Welichem Biotech Inc., XOMA Ltd., Xytis, ZIOPHARM Oncology, Inc.

Contact Information